glp-1 drug market size Agonists Weight Loss Drugs Report, 2025-2030 Market Overview: GLP-1 Agonists and
Description
However, substantial research is needed to expand their utility, optimize delivery methods, and improve patient outcomes
With retatrutide and other multi-agonists on the horizon, we may soon see drugs that approach the effectiveness of bariatric surgery without the invasiveness
Non-HDL cholesterol, which is total cholesterol minus the so-called "good" HDL fraction, fell by around 27% at 48 weeks [5]
Hossain MA, Kitagaki S, Nakano D, et al
Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, et al
